Unos esteroides de uso común podrían alterar al cerebro
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El uso de esteroides a largo plazo puede remodelar a la estructura del cerebro, y hacer que algunas partes se encojan y otras crezcan, informa un nuevo e importante estudio.Las personas que toman est…
Learn MoreUnos esteroides de uso común podrían alterar al cerebro
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El uso de esteroides a largo plazo puede remodelar a la estructura del cerebro, y hacer que algunas partes se encojan y otras crezcan, informa un nuevo e importante estudio.Las personas que toman est…
Learn MoreIn Small Study, Hormone Boosts Thinking Skills in Men With Down Syndrome
THURSDAY, Sept. 1, 2022 (HealthDay News) — Men with Down syndrome may think and remember better when treated with a brain hormone normally associated with fertility, a new small-scale study suggests.Rhythmic drip doses of gonadotropin-releasing hormo…
Learn MoreHow ‘This Is Us’ Put Alzheimer’s Care in the Spotlight
THURSDAY, Sept. 1, 2022 (HealthDay News) — When the wildly popular TV show “This Is Us” wrapped up its final season this year, it did so with a storyline that showed one of the lead characters dealing with Alzheimer’s disease as her adult children di…
Learn MoreWidely Used Steroid Meds Could Alter the Brain
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Long-term steroid use can reshape the structure of the brain, causing some parts to shrink and others to grow, a major new study reports.People taking steroids — even inhaled steroids — appear to have les…
Learn MoreTight Blood Sugar Control Boosts Brain Power of Teens With Type 1 Diabetes: Study
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — When teenagers with type 1 diabetes get better control of their blood sugar, their brains may benefit, a new clinical trial shows.Researchers found that when teenagers started treatment with a newer technol…
Learn MoreUblituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Patients with relapsing multiple sclerosis receiving ublituximab have lower annualized relapse rates and fewer brain lesions on magnetic resonance imaging than those receiving teriflunomide, according to a …
Learn MoreBrain Study Shows How Fentanyl Kills
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Fentanyl, the synthetic opioid that’s driving a surge in drug overdose deaths, kills by stopping breathing even before someone loses consciousness, a new study reveals. To come to that conclusion, researche…
Learn MoreDeep Brain Stimulation Shows Promise Against Binge Eating Disorder
TUESDAY, Aug. 30, 2022 (HealthDay News) — Electrically stimulating the brain’s “reward” circuity may hold promise as a treatment for binge eating disorder, a small pilot study suggests.The findings are based on just two patients who received deep bra…
Learn MoreSchool Sports Are Starting Again: Know the Signs of Concussion
SUNDAY, Aug. 28, 2022 (HealthDay News) — As high school sports get underway this fall, sports medicine specialists remind athletes, parents and coaches that concussions can be challenging to diagnose.Dr. Sean Bradley, a primary care sports medicine p…
Learn More